Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids. - Wikidata - awgldk - TriplyDB

Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

http://www.wikidata.org/entity/Q42245251

about

Mouse models for human otitis media Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A.Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.Ion homeostasis in the ear: mechanisms, maladies, and management.Early investigational drugs for hearing loss.Altered expression of middle and inner ear cytokines in mouse otitis media.Control of middle ear inflammatory and ion homeostasis genes by transtympanic glucocorticoid and mineralocorticoid treatments.Correlative mRNA and protein expression of middle and inner ear inflammatory cytokines during mouse acute otitis media.Autoimmune sensorineural hearing loss: the otology-rheumatology interface.Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs.Inner ear tissue remodeling and ion homeostasis gene alteration in murine chronic otitis media.

P2860

Q27491017-A6BF1225-5BCB-4253-9546-152750FA4BDA Q28388403-EBEE24EA-07BA-442A-B55C-8C743E4E0D48 Q30383830-11A66062-D979-493A-A2E3-63B20C994808 Q30430796-3417C820-BB18-447B-9503-43D77077921B Q30439269-1118DC8E-8ADE-449D-B9B4-C9CA3525213D Q30473907-8DE627F4-EAAD-4358-8F82-3D121B6AF11F Q33847686-E572DD99-4641-4847-815B-9C8053632553 Q34787859-3FD8F456-9E08-433A-823F-35996ED966C4 Q35587454-42AB3321-7F0C-4EDF-B727-1DF6F3E7731C Q35822607-E4D18922-9B9D-41E3-B0A7-D9B036D39348 Q38084236-D7A5C3C9-20BF-47FF-9194-CE6330545EF9 Q38547824-D7C0713D-44D3-4A61-A8FA-DC0C1F30711C Q41988399-A31C2B1A-2FB8-4362-BD40-8D6C53422536

P2860

Control of chronic otitis media and sensorineural hearing loss in C3H/HeJ mice: glucocorticoids vs mineralocorticoids.

http://www.wikidata.org/entity/Q42245251

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@en

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@nl

type

label

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@en

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@nl

prefLabel

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@en

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@nl

P1433

Q42245251-B2D22D94-AFF5-48B2-9231-DCAB700CBF98

P1476

Q42245251-4780D5E7-AD7F-4B7D-8904-FDC135186314

P2093

Q42245251-43CD0149-1F47-4806-9E6C-6520E8597C7C

Q42245251-79B195E9-9E26-43DA-84F6-C427A986E200

Q42245251-94AE9DF6-6AF3-45B0-81F5-68B45EDFBCF6

Q42245251-ACD7D5B0-E465-4B9F-ADE4-4496D07211F5

P2860

Q42245251-0EF7AE2E-C222-4A66-AFEF-F36A33C453C0

Q42245251-1283A430-AA7F-4E97-9942-86C868E4868A

Q42245251-282796C4-43C7-4C9C-AC50-6742751DE014

Q42245251-2D2D2C7C-1F0D-4819-BE4A-06CE5655FFE5

Q42245251-311D24C5-213E-480C-8D76-CD2F7FC49D04

Q42245251-38B72B9A-7179-4153-AFC9-2BDDCBBC4490

Q42245251-38E2EA4B-CD1B-4812-B832-C89BFC3AAD7A

Q42245251-61D0E6E6-79EB-4E1E-948C-156108C90ACD

Q42245251-6309AA8F-8398-45A8-90A1-D30E549084E4

Q42245251-9FF893AB-E194-46CD-8AFB-CF60411CCCB1

P304

Q42245251-7310AD9A-4DC2-41FA-BF24-918DF19DE247

P31

Q42245251-9CB9CC49-FF00-4066-BDDE-3F2D9D4694EC

P356

Q42245251-F4538214-674E-4832-9E55-2AE74D988907

P433

Q42245251-C11FEEB7-131B-4AAE-A036-FB39DBCD8ACB

P478

Q42245251-4DD6BD70-9D25-4DD1-A0F9-E86C2CB6EA8A

P577

Q42245251-549327FB-3075-4BA4-9575-429E8DE57863

P5875

Q42245251-C5DA7CAC-A30B-43BE-A98B-A462BAC45AF4

P698

Q42245251-DEB5B49C-E776-49FB-AF2F-90CA5EA38AA5

P932

Q42245251-755494B1-B806-4FC7-8004-9C5F639A0226

P356

J.OTOHNS.2008.07.029

P1433

Otolaryngology-Head and Neck Surgery

P1476

Control of chronic otitis medi ...... ticoids vs mineralocorticoids.

@en

P2093

Carol J MacArthur

http://www.w3.org/2001/XMLSchema#string

Dennis R Trune

http://www.w3.org/2001/XMLSchema#string

J Beth Kempton

http://www.w3.org/2001/XMLSchema#string

Jacqueline DeGagne

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children.

Enhanced sodium absorption in middle ear epithelial cells cultured at air-liquid interface.

Glucocorticosteroids increase sodium transport in middle ear epithelium.

Cochlear changes in chronic otitis media.

Systemic steroid for chronic otitis media with effusion in children.

ENaC- and CFTR-dependent ion and fluid transport in human middle ear epithelial cells.

In vivo demonstration of the absorptive function of the middle ear epithelium.

Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.

The use of a 56-stimulus train for the rapid acquisition of auditory brainstem responses.

P304

646-653

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OTOHNS.2008.07.029

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23451558

http://www.w3.org/2001/XMLSchema#string

P698

18984258

http://www.w3.org/2001/XMLSchema#string

P932

2907070

http://www.w3.org/2001/XMLSchema#string